DSS INC (DSS)

US26253C2017 - Common Stock

1.81  -0.05 (-2.69%)

After market: 1.7903 -0.02 (-1.09%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DSS. DSS was compared to 84 industry peers in the Commercial Services & Supplies industry. DSS has a bad profitability rating. Also its financial health evaluation is rather negative. DSS has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year DSS has reported negative net income.
In the past year DSS has reported a negative cash flow from operations.
In multiple years DSS reported negative net income over the last 5 years.
In the past 5 years DSS always reported negative operating cash flow.

1.2 Ratios

DSS has a Return On Assets of -39.28%. This is amonst the worse of the industry: DSS underperforms 91.57% of its industry peers.
The Return On Equity of DSS (-81.90%) is worse than 84.34% of its industry peers.
Industry RankSector Rank
ROA -39.28%
ROE -81.9%
ROIC N/A
ROA(3y)-11.23%
ROA(5y)-7.71%
ROE(3y)-21.84%
ROE(5y)-13.96%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 15.75%, DSS is not doing good in the industry: 73.49% of the companies in the same industry are doing better.
DSS's Gross Margin has declined in the last couple of years.
DSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.69%
GM growth 5Y-12.69%

1

2. Health

2.1 Basic Checks

DSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
DSS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DSS has more shares outstanding
DSS has a worse debt/assets ratio than last year.

2.2 Solvency

DSS has an Altman-Z score of -2.02. This is a bad value and indicates that DSS is not financially healthy and even has some risk of bankruptcy.
DSS has a worse Altman-Z score (-2.02) than 87.95% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that DSS is not too dependend on debt financing.
DSS's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. DSS outperforms 73.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -2.02
ROIC/WACCN/A
WACC6.45%

2.3 Liquidity

A Current Ratio of 0.46 indicates that DSS may have some problems paying its short term obligations.
With a Current ratio value of 0.46, DSS is not doing good in the industry: 92.77% of the companies in the same industry are doing better.
DSS has a Quick Ratio of 0.46. This is a bad value and indicates that DSS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DSS (0.38) is worse than 92.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.38

3

3. Growth

3.1 Past

The earnings per share for DSS have decreased strongly by -481.08% in the last year.
Looking at the last year, DSS shows a very negative growth in Revenue. The Revenue has decreased by -19.22% in the last year.
Measured over the past years, DSS shows a very strong growth in Revenue. The Revenue has been growing by 20.45% on average per year.
EPS 1Y (TTM)-481.08%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-166.67%
Revenue 1Y (TTM)-19.22%
Revenue growth 3Y44.9%
Revenue growth 5Y20.45%
Revenue growth Q2Q-64.76%

3.2 Future

DSS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.50% yearly.
The Revenue is expected to decrease by -21.30% on average over the next years. This is quite bad
EPS Next Y96.95%
EPS Next 2Y41.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-34.74%
Revenue Next 2Y-21.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

DSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 179.21, which means the current valuation is very expensive for DSS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DSS indicates a slightly more expensive valuation: DSS is more expensive than 60.24% of the companies listed in the same industry.
DSS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.79.
Industry RankSector Rank
PE N/A
Fwd PE 179.21

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as DSS's earnings are expected to grow with 41.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.5%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DSS!.
Industry RankSector Rank
Dividend Yield N/A

DSS INC

NYSEARCA:DSS (3/28/2024, 8:05:47 PM)

After market: 1.7903 -0.02 (-1.09%)

1.81

-0.05 (-2.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap12.69M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 179.21
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.28%
ROE -81.9%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 15.75%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.46
Quick Ratio 0.38
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-481.08%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y96.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-19.22%
Revenue growth 3Y44.9%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y